Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model

Imiquimod is an imidazoquinoline immune response modifier that is used in antiviral and antiallergic creams. Combination therapy using transcutaneous imiquimod and oral sorafenib was previously demonstrated to reduce the tumor burden of renal cell carcinoma growing cutaneously in a mouse model. In t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: Karashima, Takashi, Udaka, Keiko, Niimura, Mayumi, Suzuki, Katsuhide, Osakabe, Hiroto, Shimamoto, Tsutomu, Fukata, Satoshi, Inoue, Keiji, Kuroda, Naoto, Seiki, Motoharu, Shuin, Taro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2017
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494610/
https://ncbi.nlm.nih.gov/pubmed/28693290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6235
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak